TF Capital is a global biotech-focused investment firm that partners with early-stage biopharma innovators, providing capital and strategic expertise across the value chain. It operates with a global footprint including Shanghai, Boston, and Ireland, and emphasizes proprietary sourcing, exclusive founder relationships, and diverse partnerships with listed companies and leading clinical experts. The firm highlights impactful investments with a track record of licensing deals and significant upfronts, supporting portfolio growth and cross-regional collaboration. TF Capital manages capital with a global expansion strategy to identify and nurture the most promising biotech companies worldwide.
No recent deals for this company.